No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CRH240621P80000
- 3.59
- +2.21+160.14%
15min DelayClose Jun 14 16:00 ET
3.59High3.34Low
3.55Open1.38Pre Close10 Volume2.74K Open Interest80.00Strike Price3.43KTurnover28.19%IV0.18%PremiumJun 21, 2024Expiry Date3.45Intrinsic Value100Multiplier5DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type-0.8911Delta0.0756Gamma21.56Leverage Ratio-0.0349Theta-0.0074Rho-19.21Eff Leverage0.0178Vega
Intraday
- 5D
- 1D
News
Express News | CRH Shares Are Trading Lower. The Company Announced Its Acquisition of Adbri With Barro Group Received Court and Shareholder Approval
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
European equities traded in the US as American depositary receipts were trending sharply lower Friday, falling 1.3% to 1,404.81 on the S&P Europe Select ADR Index, which is set to end the week down 1.
Investors in CRH (NYSE:CRH) Have Seen Strong Returns of 165% Over the Past Five Years
CRH Acquisition Cleared for Takeoff: A$2.1B Deal Bolsters Australia Presence
CRH plc (NYSE:CRH) shares are trading lower on Friday. The company disclosed that Adbri's independent shareholders had approved the Scheme of Arrangement for CRH and the Barro Group to acquire Adbri L
CRH And Barro Group's A$2.1B Acquisition Of Adbri Receives Court And Shareholder Approval
Under the approved Scheme, CRH will acquire the remaining 57% of the ordinary shares of Adbri not owned by Barro for the previously agreed cash consideration of A$3.20 per share. The Offer values Adbr
Express News | CRH PLC - Offer Values Adbri at an Equity Valuation of a$2.1 Bln (US$1.4 Bln) on a 100% Basis
Comments
G'day, mooers! Check out the latest news on today's stock market!
• US major indexs fell
• ASX 200 rises by broad buying; ANZ sells stake in Malaysian bank
• Stocks to watch: Telix Pharmaceuticals, Adbri, Pro Medicus
Wall Street Summary
Indexs fell Thursday after harsh earnings reactions. Overall, there was more green than red out there, but by the numbers after the close, the $S&P 500 Index(.SPX.US$ traded -0.60%,...
• US major indexs fell
• ASX 200 rises by broad buying; ANZ sells stake in Malaysian bank
• Stocks to watch: Telix Pharmaceuticals, Adbri, Pro Medicus
Wall Street Summary
Indexs fell Thursday after harsh earnings reactions. Overall, there was more green than red out there, but by the numbers after the close, the $S&P 500 Index(.SPX.US$ traded -0.60%,...
2
CRH's dividend is seen as sustainable, backed by profit and cash flow. Its growing earnings and low payout ratios hint at a promising long-term dividend stock. The firm's consistent dividend and earnings growth show a commitment to rewarding shareholders.
1
Despite lower than expected Q4 numbers, investors are not worried due to the company's positive outlook for 2024, driven by significant infrastructure investment and re-industrialization activity across key markets in North America and Europe.
The strong EPS growth and insider buying at CRH indicate a positive outlook for the company. The growth rate and insider activity suggest that the company could be a good investment opportunity.
1
The market's view of CRH has improved over the last five years, likely due to consistent earnings growth. Recent insider buying and strong share price momentum suggest potential investment opportunities.
Read more